Nanoparticles and nanotechnology - PowerPoint PPT Presentation

1 / 50
About This Presentation
Title:

Nanoparticles and nanotechnology

Description:

the more I realise I don't know anything. I am likely to be ... Serpentine. Chrysotile. Fibrous amphiboles. Actinolite. Amosite. Anthophyllite. Crocidolite ... – PowerPoint PPT presentation

Number of Views:300
Avg rating:3.0/5.0
Slides: 51
Provided by: davemc89
Category:

less

Transcript and Presenter's Notes

Title: Nanoparticles and nanotechnology


1
Nanoparticles and nanotechnology
  • Dr Martin Cosgrove
  • MB ChB FRCGP MFOM
  • Consultant Occupational Physician

2
Warning!
  • Personal account
  • The more I know,
  • the more I realise I dont know anything
  • I am likely to be wrong about some things,
  • but not possible to know what or how much by
  • If all you ask is questions
  • More uncertainty

3
Overview
  • Cell biology
  • Existing knowledge base
  • Nano materials Carbon nanotubes
  • HS

4
The Cell
Credit STEVE GSCHMEISSNER
5
Mitochondrion
500nm x 2 to 5000 nm
Credit BILL LONGCORE
6
Cell Microtubules
25 nm diameter
Credit THOMAS DEERINCK, NCMIR
7
The biological scale
10µm 1 µm 100nm 10nm
Nucleus 3-14 µm diameter Cilia 5-15
long Mitochondrion 0.5x 2 to 5 µm
Centriole 150nm x 300 to 500 nm Cell membranes
7.5 to180 nm thick Ribosomes 15-25 nm
diameter Microtubules 25 nm diameter
8
Cell division
Credit DR ALEXEY KHODJAKOV
9
Deposition of particles in the lung
Total body deposition
1 0.5 0
Deposition fraction
Alveolar deposition
0.001 0.01 0.1 1 10
100 Particle size µm
10
Fate of UFPs in the lungs
  • Soluble particle dissolved in mucus, absorbed
    into circulation
  • Slowly dissolving and insoluble particles
  • on airway wall coughed up
  • in alveolus phagocytosis by macrophages
  • Remains in lung
  • Transported into circulation small

11
Cell uptake
  • Pinocytosis
  • Biodistribution
  • Localisation in tissues
  • Lung, liver, spleen,
  • bone marrow,
  • brain and lymph nodes

12
Particulate air pollution
  • PM10 Course particles 2.5 10 µm diameter
  • PM2.5 Fine particles lt2.5 µm diameter
  • PM1 Ultrafine particles lt100 nm diameter

13
Air pollution in the West
  • Burning three rings of domestic gas
  • 50 x 103 UFP / cm3
  • London 10 - 50 x 103 UFP/cm3
  • European cities 15 -18 x103 UFP/cm3
  • USA 106 UFP / cm3 in busy road area

14
Effects of air pollution
  • For every increase of 10µg/m3 in PM2.5
    ?mortality by 6
  • Cardiovascular disease
  • Chronic lung disease
  • But not a problem in welders or kitchen staff
    despite UFP exposure

15
Asbestos
  • Serpentine
  • Chrysotile
  • Fibrous amphiboles
  • Actinolite
  • Amosite
  • Anthophyllite
  • Crocidolite
  • Tremolite

long curved flexible fibres, break easily
stiffer fibres, do not break so easily
16
Crocidolite SEM false colour
CreditDR JEREMY BURGESS Magnification x60
17
Asbestos fibre with macrophages impaled
macrophage
Credit PHOTO INSOLITE REALITE
18
Effects of asbestos
  • Lung cancer
  • Increased in asbestos workers
  • Multiplicative effect of smoking and asbestos
    exposure
  • Asbestosis
  • Mesothelioma

19
Mesothelium
  • Internal skin surrounding the lung and the
    abdominal organs
  • Occasionally becomes malignant mesothelioma
    2000 cases/year UK
  • Much more likely to become malignant if exposed
    to asbestos, particularly amphiboles
  • Long lag time between exposure and cancer

20
Mesothelioma
Credit science photo library
21
Hazardous asbestos fibre
  • Thinner than 3 µm
  • Longer than 15-20 µm
  • Bio-persistent in the lungs does not dissolve
    or break into smaller fibres
  • Must reach a concentration level to cause chronic
    inflammation, genotoxicity, fibrosis and cancer
    in target cells

22
Nanoparticles
  • Nanos Greek, a dwarf
  • Nano Scientific term, a billionth
  • Particle up to 100 nm in at least one dimension
    created by engineering
  • Below 50nm subject to quantum rather than
    Newtonian physics
  • With decreasing size, more atoms are at the
    surface

23
Examples of nanoparticles
  • Fullerenes
  • Nanotubes
  • Nanowires
  • Quantum dots
  • Plasmons
  • Aim is N3
  • nMeters
  • nJoules
  • nSeconds

24
The Market
Nano medicine
Nano metrology
Nano materials / nano particles
Nano fabrication
2007 value US 1,1000,000,000,000
25
The scale of nanoparticles
Eukaryotes gt5 µm Bacteria 0.5-3 µm Herpes virus
100 nm Adenovirus 70-90 nm Parvovirus 18-26 nm
10µm 1 µm 100nm 10nm 1nm 0.1nm 0.01nm
Atomic size 0.2 nm Distance between two H atoms
in Hydrogen molecule 0.07nm
26
Physico chemical properties
  • Size and shape
  • Solubility
  • Chemical composition
  • Lattice structure
  • Surface chemistry
  • Surface charge
  • Surface area
  • Aggregation state
  • Biopersistence

27
The new nano-world
  • The function of engineered nanoparticles cannot
    necessarily be predicted from their chemistry and
    physical properties alone
  • Its not a size thing!
  • It what it does that matters
  • What do we measure as regards dose?

28
Buckminsterfullerene C60
  • Uses
  • Bowling balls,
  • Tennis rackets,
  • Clothing,
  • Materials science,
  • Pharmaceuticals,
  • Resin coatings to improve controllability

0.7nm diameter
Credit David Taylor
29
Single Walled Carbon Nanotubes
  • Capped or uncapped
  • Tend to aggregate
  • Like graphite
  • Defects in hexagonal tiling
  • High surface area
  • Width 0.7 3nm
  • High aspect ratio

30
Manufacture of CNTs
Arc discharge, laser, chemical vapour deposition
Catalyst
Carbon source
Purification
High pressure or temperature
Functionalisation
31
Interactions with CNTs
  • Filling of inside of tube
  • Proteins bind strongly
  • Able to cross cell membranes
  • Bond with halogens, polymers, metals
  • SWCNTs joint together to form MWCNTs

32
MWCNTs and macrophages
  • Hirano S Multiwalled carbon nanotubes injure the
    plasma membrane of macrophages. Toxicology and
    Applied Pharmacology 2008 232 244-51
  • Porter AE. Direct imaging of single walled carbon
    nanotubes in cells. Nature nanotechnology 2007
    713-7

MWCNTs or Crocidolite
macrophage
33
MWCNTs and mesothelioma
  • Tagaki

Monitored until 100 mortality in one group
MWCNT Fullerene Crocidolite control solution
Intra-peritoneal injection into asbestos
sensitive mice
Tagaki A, Induction of mesothelioma in p53/-
mouse by intraperitoneal application of
multi-wall carbon nanotube. J Toxicol Sci 2008
33 105-15
34
MWCNT and mesothelioma
Autopsy findings
Tagaki A, Induction of mesothelioma in p53/-
mouse by intraperitoneal application of
multi-wall carbon nanotube. J Toxicol Sci 2008
33 105-15
35
The Big Question
  • Could CNTs reach the mesothelium
  • in a normal working environment?

36
Final thought on carbon nanotubes
  • For the moment, it would be no
  • bad thing if they were treated by
  • those making and using them if
  • they were asbestos.
  • Antony Seaton

37
The future
  • Fast, dynamic
  • Inadvertent exposure from imported goods
  • Overwhelming number of articles
  • Difficult to sift out what matters
  • Difficult to keep up
  • Regulation needed - but time lag
  • Nano materials are not uniform
  • Review risk assessment regularly with updated
    information

38
Actions
  • Nanotechnology safety group
  • Work out what nanomaterials you have
  • Share information
  • Make sure that the company knows that the group
    exist
  • Risk assess procedure
  • Control on basis of the risk assessment
  • Consider the environmental impact
  • End of life actions
  • Make assumptions on the basis of what is already
    known

39
Risk assessment
  • Due to the developmental nature of much of
    nanotechnology. your information may be
    incomplete.your risk assessment..should be
    suitably cautious providing higher levels of
    protection as the significance and level of
    uncertainty about the risk increases.
  • HSE Information Sheet - Nanotechnology

40
Risk assess
  • Chemistry
  • Physics
  • Surface attributes
  • Exposures at different phases of life cycle

41
Exposure potential
  • Amount of material
  • Dry powder
  • Degree of containment
  • Duration of use

42
COSHH hierarchy of control
  • Elimination
  • Substitution
  • Enclosure
  • Engineering Control
  • Procedural Control
  • PPE
  • Binding powder in liquid or solid media
  • Local exhaust ventilation
  • Limit people exposed,
  • train staff,
  • clean work wear,
  • clean workplace

43
Procedure
  • Resources
  • USA Department of Energy Nanoscale Science
    Research Centers
  • Approach to Nanomaterial ESH
  • British Standard PD6699-22007
  • Nanotechnologies Part 2
  • Guide to safe handling and disposal of
    manufactured nanomaterials

44
Health Monitoring - the options
  • No action
  • Document the presence of free unbound
    nanoparticles
  • Identify and record individual workers
  • Handles particles with potential to become
    dispersed in air
  • Routinely exposed
  • Works on equipment that might be contaminated
    with nano materials that could be released during
    servicing or breakdown
  • General medical check up
  • Targeted medical testing cardio respiratory

Schulte P et al. Options for occupational health
surveillance of workers potentially exposed to
engineered nanoparticles state of the science.
J Occup Environ Med 2008 50 517-26
45
Health promotion
  • What do we do about smoking?

46
The big five challenges
  • Develop
  • Instruments to assess exposure
  • Methods to evaluate toxicity
  • Models for predicting the potential health and
    environmental impact
  • Robust systems for evaluating the health and
    environmental impact over entire life of product
  • Strategic programmes to enable risk focussed
    research

Maynard AD, Nature 444 267-9
47
Sources of information
  • www.hse.gov.uk/
  • www.cdc.gov/niosh/topics/nanotech/ default.html
  • www.nanotechproject.org
  • www.nano.org.uk
  • www.oecd.org

48
References - Articles
  • Whatmore RW. Nanotechnology what is it? Should
    we be worried? Occupational Medicine 2006 56
    295-9
  • Aitken RJ, et al Manufacture and use of
    nanomaterials current status in the UK and
    global trends. Occupational Medicine 2006 56
    300-6
  • Garnett MC, Kallinteri P. Nanomedicines and
    nanotoxicology some physiological principles.
    Occupational Medicine 2006 56 307-11
  • Seaton A. Nanotechnology and the occupational
    physician. Occupational Medicine 2006 56 312-6
  • Schulte P et al. Occupational risk management of
    engineered nanoparticles. J Occup Environ Hyg
    2008 239-49

49
General References
  • Royal Commission on Environmental Pollution.
    Novel Materials in the environment the case of
    nanotechnology
  • HSE information note Nanotechnology
  • Nanotechnologies part 2 guide to safe handling
    and disposal of manufactured nanomaterials BSI
    PD6699-22007
  • Workplace atmospheres ultrafine, nanoparticle
    and nanostructured aerosols inhalation exposure
    characterisation and assessment BSI PD 276282007
  • Aitken RJ et al. Nanoparticles an occupational
    hygiene review. HSE research report 274. HSE
    Books 2004
  • Journal of Nanobiotechnology
  • Nature Nanotechnology
  • ISO/TR 128852008

50
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com